Peter Loskill received his PhD in physics from Saarland University in 2012 and subsequently conducted his postdoctoral research at UC Berkeley. In 2015, he was recognized by Technology Review as one of the “Innovators under 35 Germany” and was selected for the Fraunhofer ATTRACT funding program.
In 2016, he founded the µOrganoLab, whose interdisciplinary research combines approaches from engineering, biology, physics, and medicine to develop novel microphysiological tissue models that recapitulate complex human biology in vitro and can be applied to address scientific, toxicological, or pharmaceutical questions, among others.
In May 2021, he was appointed as fullkl professor for Organ-on-Chip systems between the NMI Natural and Medical Sciences Institute at the University of Tübingen in Reutlingen and the Medical Faculty of Eberhard Karl’s University Tübingen. Simultaneously, he assumed the leadership of the 3R-Center Tübingen and the Organ-on-Chip group at NMI.